Inactive Instrument

Ocata Therapeutics Inc Share Price

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

10/02/16	Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	PR
22/01/16	Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	PR
28/12/15	Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	BU
03/12/15	Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	BU
24/11/15	Ocata Therapeutics : Harwood Feffer LLP : Announces Investigation of Ocata Therapeutics, Inc.	PR

Manager	Title	Age	Since
John Heffernan PRN	Corporate Officer/Principal	-	02/02/2015

Director	Title	Age	Since
Toru Yoshimitsu BRD	Director/Board Member	63	-
Masaaki Hirano BRD	Director/Board Member	59	-
Percival Barretto-Ko BRD	Director/Board Member	53	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	-2.48%	-2.22%	+55.85%	+79.12%	53.54B
ARGENX SE	-0.21%	-6.75%	+55.40%	+126.77%	54.18B
INSMED INCORPORATED	-0.86%	-4.75%	+5.49%	+421.75%	23.66B
BIONTECH SE	+0.03%	-4.46%	-18.84%	-16.77%	22.78B
WUXI BIOLOGICS (CAYMAN) INC.	+2.36%	+1.06%	+43.34%	-6.14%	19.54B
GENMAB A/S	-2.29%	-1.66%	+35.93%	-28.95%	17.82B
PHARMAESSENTIA CORPORATION	-4.00%	-7.88%	+175.60%	+343.60%	16.01B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.15%	-4.83%	+46.53%	+627.30%	15.37B
EXELIXIS, INC.	-1.27%	-2.94%	+21.54%	+185.71%	14.09B
Average	-1.09%	-2.45%	+46.76%	+192.49%	26.33B
Weighted average by Cap.	-1.10%	-2.46%	+46.46%	+159.60%

Employees

Sector